Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
Articles 1 - 3 of 3
Full-Text Articles in Chemicals and Drugs
A Brief Discussion Of Gasdermin D'S Function In Multiple Sclerosis, Amie Brint
A Brief Discussion Of Gasdermin D'S Function In Multiple Sclerosis, Amie Brint
Arkansas Women in STEM Conference
Multiple Sclerosis (MS) is a neurodegenerative disease that particularly affects the nerves of the central nervous system (CNS). MS results in the degradation of the myelin sheath surrounding the axon, which is crucial for effective transmission of nerve signals. MS can be detected using lumbar punctures to look for elevated oligoclonal levels and using magnetic resonance imaging (MRI). The MRI can screen for plaques in the CNS, indicating the severity and probability of progression of the disease. Plaques are regions of nerves where the myelin has been removed from the nerves, preventing them from conducting the electrical signals necessary for …
Combination Chemo-Pdt Ionic Nanomedicines As Enhanced Therapeutics For Cancer, Samantha Macchi
Combination Chemo-Pdt Ionic Nanomedicines As Enhanced Therapeutics For Cancer, Samantha Macchi
Arkansas Women in STEM Conference
Cancer remains as one of the leading causes of death in humans worldwide. Nanotechnology has made great strides in improving treatment for the disease. This work describes a simplistic approach to design self-assembled combination nanomedicines. A facile one-step ion exchange reaction is utilized to combine a chemotherapeutic (phosphonium) cation and photodynamic therapeutic (porphyrin) anion. An aqueous nanomedicine is prepared from the hydrophobic ionic combination drug via a single-step reprecipitation method. Upon conversion to ionic combination drug, improved photophysical properties of porphyrin were observed. These characteristics subsequently led to increased photodynamic therapeutic activity of nanomedicines—explained by greater singlet oxygen quantum yield. …
Lowering The Cost And Raising The Efficiency Of A Cure To Chagas Disease, Madeleine Peters
Lowering The Cost And Raising The Efficiency Of A Cure To Chagas Disease, Madeleine Peters
Arkansas Women in STEM Conference
Chagas disease, classified as a neglected tropical disease (NTD), is caused by the parasite Trypanosoma cruzi and is an underfunded and under researched disease. The only FDA-approved drug in the United States is benznidazole which is expensive, harmful, and only effective in the illness’ acute phase. The goal is to create a more effective, lower costing and less harmful drug by using a condensation reaction to substitute different amines to diethyl squarate (DES) to make cycloalkylsquaramides. Both DES and the amines used are relatively low in price with a simple, efficient, and high yielding synthesis. Low synthetic cost and ability …